Nichi-Iko Pharmaceutical Co., Ltd.

<h3>3. Dividend Policy</h3>
The Company considers the consistent return of appropriate profits to shareholders as one of its key policies. Dividends are determined based on business performance, while also taking into account the dividend payout ratio, further strengthening of the Company's financial position, and the need to maintain sufficient retained earnings to support future business development.
The Company's basic policy is to pay dividends twice annually: an interim dividend at the end of the second quarter and a year-end dividend. The year-end dividend is decided by the shareholders' meeting, while the interim dividend is decided by the board of directors.
The Company's articles of incorporation provide that an interim dividend may be paid with a record date of September 30 each year, subject to board of directors' resolution.
For the current fiscal year, due to a net loss of 74,635 million yen for the fiscal year ended March 2022, we regret to inform that no dividend will be paid.

We base our dividend policy on business performance while also considering the dividend payout ratio and the need to build internal reserves for strengthening our financial position and funding future business expansion. We distribute dividends twice annually—at the end of the second quarter and at the fiscal year-end.

Nichi-Iko Pharmaceutical Co., Ltd. (E00963) Dividends

Dividend Policy

Dividend per Share

Payout Ratio

Dividend Yield

Dividend History (Forecasts, Revisions, Actuals)